Back
Galectin Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
GALT
Galectin Therapeutics
Last Price:
$1.03
Seasonality Move:
33.46%
7 Day Trial
ALL ACCESS PASS
$
7
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight selling pressure.
Galectin Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.94 | Sell |
| 20-day SMA: | 2.26 | Sell |
| 50-day SMA: | 2.51 | Sell |
| 200-day SMA: | 2.64 | Sell |
| 8-day EMA: | 1.86 | Sell |
| 20-day EMA: | 2.15 | Sell |
| 50-day EMA: | 2.4 | Sell |
| 200-day EMA: | 2.46 | Sell |
Galectin Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 20.76 | Sell |
| Chaikin Money Flow: | -1963460 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.91 - 2.81) | Sell |
| Bollinger Bands (100): | (2.2 - 2.82) | Sell |
Galectin Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Galectin Therapeutics Stock
Is Galectin Therapeutics Stock a Buy?
-
Galectin Therapeutics share price is 1.03 while GALT 8-day simple moving average is 1.94, which is a Sell signal.
-
The stock price of GALT is 1.03 while Galectin Therapeutics 20-day SMA is 2.26, which makes it a Sell.
-
Galectin Therapeutics 50-day simple moving average is 2.51 while GALT share price is 1.03, making it a Sell technically.
-
GALT stock price is 1.03 and Galectin Therapeutics 200-day simple moving average is 2.64, creating a Sell signal.
GALT Technical Analysis vs Fundamental Analysis
Sell
14
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy or a Sell?
-
Galectin Therapeutics stock is rated a SellThe current Galectin Therapeutics [GALT] share price is $1.03. The Score for GALT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Galectin Therapeutics Stock Info
Market Cap:
64.6M
Price in USD:
1.03
Share Volume:
9.2M
Galectin Therapeutics 52-Week Range
52-Week High:
4.27
52-Week Low:
0.73
Sell
14
Galectin Therapeutics (GALT)
is a Sell
Galectin Therapeutics Share Price Forecast
-
What is the Galectin Therapeutics stock price today?The Galectin Therapeutics stock price is 1.03 USD today.
-
Will GALT stock go up or go down?Galectin Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Galectin Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galectin Therapeutics is overvalued.
Is Galectin Therapeutics Stock a Buy?
-
Galectin Therapeutics share price is 1.03 while GALT 8-day exponential moving average is 1.86, which is a Sell signal.
-
The stock price of GALT is 1.03 while Galectin Therapeutics 20-day EMA is 2.15, which makes it a Sell.
-
Galectin Therapeutics 50-day exponential moving average is 2.40 while GALT share price is 1.03, making it a Sell technically.
-
GALT stock price is 1.03 and Galectin Therapeutics 200-day simple moving average is 2.46, creating a Sell signal.
Technical Analysis of Galectin Therapeutics
Should I short Galectin Therapeutics stock?
-
GALT Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Galectin Therapeutics is a Sell
-
Galectin Therapeutics Relative Strength Index (RSI) is 20.76, which suggest Galectin Therapeutics is oversold
-
The Bollinger Bands (25) for Galectin Therapeutics is (1.91 - 2.81), which suggest Galectin Therapeutics is a Sell
-
The Bollinger Bands (100) for Galectin Therapeutics is (2.2 - 2.82), which suggest Galectin Therapeutics is a Sell
* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.